Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009

Medical Journal of Australia

Volumn 193, Issue 7, 2010, Pages 392-396

  Hanna, Jeffrey N ^a   Humphreys, Jan L ^b   Murphy, Denise M ^c   Smith, Helen V ^c  

^a Division of the Chief Health Officer   (Australia)

^b Division of the Chief Health Officer   (Australia)

^c QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CHILD; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROTYPE; TREND STUDY;

EID: 77958073895     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03965.x     Document Type: Article

References (18)

1. National Health and Medical Research Council. Pneumococcal infections. In: The Australian immunisation handbook. 8th ed. Canberra: Commonwealth of Australia, 2003: 220-234.
2. Whitney CG, Moore MR. Direct and indirect effectiveness and safety of pneumococcal conjugate vaccine in practice. In: Siber GR, Klugman KP, Mäkelä PH, editors. Pneumococcal vaccines: the impact of conjugate vaccine. Washington, DC: ASM Press, 2008: 353-368.
3. Park IH, Pritchard DG, Cartee R, et al. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007; 45: 1225-1233. (Pubitemid 46626489)
4. Australian Bureau of Statistics. Australian demographic statistics: September quarter 2009. Canberra: ABS, 2010. (ABS Cat. No. 3101.0.) http://www.ausstats.abs.gov.au/Ausstats/ subscriber.nsf/0/26D01CDE59A47371CA 2576F0001C7F50/$File/31010-sep%202009.pdf (accessed Apr 2010).
5. Bailar JC, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964; 20: 639-643.
6. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201: 32-41.
7. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295: 1668-1674.
8. Park SY, Van Beneden CA, Pilishvili T, et al. Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr 2010; 156: 478-483.
9. Hanna JN, Humphreys JL, Murphy DM. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007. Med J Aust 2008; 189: 43-46.
10. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197: 1016-1027.
11. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007; 3: e168.
12. Hull B, Deeks S, Menzies R, McIntyre P. Immunisation coverage annual report, 2007. Commun Dis Intell 2009; 33: 170-187.
13. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; (1): CD000422.
14. Jackson LA, Neuzil KM. Pneumococcal polysaccharide vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia: Saunders Elsevier, 2008: 569-604.
15. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206-2216.
16. Northern Territory Centre for Disease Control. Change to Northern Territory childhood vaccination schedule 1 October 2009. NT Dis Control Bull 2009; 16 (3): 14-15.
17. Health Protection Agency (UK). Introduction of Prevenar 13™ into the Childhood Immunisation Programme. Health Protection Rep 2010; 4 (6). http://www.hpa.org.uk/hpr/archives/2010/news0610.htm#prvnr (accessed Mar 2010).
18. Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 258-261.